BDRXBiodexa Pharmaceuticals Plc

Nasdaq midatechpharma.com


$ 1.02 $ 0.02 (2 %)    

Wednesday, 08-May-2024 13:41:02 EDT
QQQ $ 439.98 $ 1.75 (0.4 %)
DIA $ 390.26 $ 1.97 (0.51 %)
SPY $ 517.17 $ 1.91 (0.37 %)
TLT $ 90.30 $ 0.00 (0 %)
GLD $ 214.04 $ 0.40 (0.19 %)
$ 1
$ 1.06
$ 0.00 x 0
$ 1.09 x 100
$ 1.02 - $ 1.08
$ 0.67 - $ 20.80
248,326
na
1.19B
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biodexas-licensor-emtora-to-announce-phase-2-clinical-trial-results-of-erapa-in-familial-adenomatous-polyposis-to-be-presented-at-prestigious-2024-digestive-disease-week-annual-meeting

Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Pres...

 biodexa-enters-into-exclusive-license-to-erapa-a-phase-3-ready-asset-for-the-treatment-of-familial-adenomatous-polyposis-worldwide-rights-come-with-17m-in-non-dilutive-grant-funding-for-pivotal-phase-3-trial-in-fap

Biodexa Pharmaceuticals PLC("Biodexa" or the "Company")Biodexa Enters Into Exclusive License to eRapa™, a Phase...

 crude-oil-surges-over-2-msc-industrial-shares-fall-after-q2-results

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow tr...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION